Liu YY - Search Results

1

Low incidence of hepatitis B virus reactivation in patients with hematological malignancies receiving novel anticancer drugs: A report from a high epidemic area and literature review.

Yan Z, Luo XF, Yao SN, Wang HY, Chu JF, Zhao S, Song M, Wei XD, Zhou KS, Li YF, Zhou WP, Zhang JY, Zhang PP, Zhou LL, Wang XW, Yao ZH, Liu YY. Yan Z, et al. Among authors: liu yy. J Microbiol Immunol Infect. 2023 Aug;56(4):747-756. doi: 10.1016/j.jmii.2023.04.003. Epub 2023 Apr 13. J Microbiol Immunol Infect. 2023. PMID: 37080838 Free article. Review.

2

[MEKK2 regulates the production of interleukin 2].

Wei XD, Fan RH, Zhu XH, Li YF, Zhang YL, Gao QL, Liu YY, Wang P, Song YP. Wei XD, et al. Among authors: liu yy. Zhonghua Xue Ye Xue Za Zhi. 2005 May;26(5):296-8. Zhonghua Xue Ye Xue Za Zhi. 2005. PMID: 15949294 Chinese.

3

[Application of all-trans retinoic acid combining chemotherapy and As4S4 in the maintenance treatment of patients with acute promyelocytic leukemia].

Lin QD, Wei XD, Wang P, Liu YY, Zhang LN, Li YF, Gao QL, Zhu XH, Zhang YL, Fang BJ, Yue H, Du JW, Jiang DX, Hu JY, Song YP. Lin QD, et al. Among authors: liu yy. Zhonghua Xue Ye Xue Za Zhi. 2007 Jan;28(1):19-21. Zhonghua Xue Ye Xue Za Zhi. 2007. PMID: 17649720 Clinical Trial. Chinese.

4

[The efficacy of high-dose cytarabine for patients with t(8;21) AML and with normal karyotype AML].

Li HY, Yue H, Wei XD, Zhu XH, Zhang YL, Zhang LN, Liu YY, Wang P, Fang BJ, Li YF, Song YP. Li HY, et al. Among authors: liu yy. Zhonghua Xue Ye Xue Za Zhi. 2008 Feb;29(2):110-2. Zhonghua Xue Ye Xue Za Zhi. 2008. PMID: 18681312 Chinese.

5

PTEN tumor suppressor plays less prognostic role than P53 tumor suppressor in diffuse large B-cell lymphoma.

Liu YY, Yao SN, Zhao Y, Yao ZH, Ma J, Xia QX, Fu K, Yang SJ. Liu YY, et al. Leuk Lymphoma. 2010 Sep;51(9):1692-8. doi: 10.3109/10428194.2010.502584. Leuk Lymphoma. 2010. PMID: 20807096

6

p63 Expression is a prognostic factor in colorectal cancer.

Guo HQ, Huang GL, Liu OF, Liu YY, Yao ZH, Yao SN, Zhao Y, Liu T, Pu XX, Lin TY, Yang SJ. Guo HQ, et al. Among authors: liu yy, liu of, liu t. Int J Biol Markers. 2012 Oct 8;27(3):e212-8. doi: 10.5301/JBM.2012.9581. Int J Biol Markers. 2012. PMID: 23015401 Free article.

7

[Inhibitory effects of celecoxib combined with capecitabine on H22 hepatoma mice and its mechanism].

Yao ZH, Yuan YD, Liu YY, Guo HQ, Zhao Y, Yao SN, Yang SJ. Yao ZH, et al. Among authors: liu yy. Zhongguo Yi Xue Ke Xue Yuan Xue Bao. 2013 Aug;35(4):447-50. doi: 10.3881/j.issn.1000-503X.2013.04.017. Zhongguo Yi Xue Ke Xue Yuan Xue Bao. 2013. PMID: 23987495 Chinese.

8

[A multi-center retrospective study of L-asparaginase-based regimens as first-line treatment in newly diagnosed extranodal NK/T-cell lymphoma].

Yuan F, Wei X, Yin Q, Li Y, Mi R, Ai H, Yang H, Li H, Ge S, Liu Y, Song Y. Yuan F, et al. Zhonghua Xue Ye Xue Za Zhi. 2014 Jul;35(7):614-8. doi: 10.3760/cma.j.issn.0253-2727.2014.07.010. Zhonghua Xue Ye Xue Za Zhi. 2014. PMID: 25052604 Chinese.

9

[Efficacy and safety of fixed dose rate gemcitabine infusion in combination with docetaxel in patients with relapsed/refractory soft tissue sarcoma].

Yao Z, Yang S, Zhao Y, Yao S, Guo H, Liu Y. Yao Z, et al. Zhonghua Zhong Liu Za Zhi. 2014 Jul;36(7):541-5. Zhonghua Zhong Liu Za Zhi. 2014. PMID: 25327662 Chinese.

10

L-asparaginase-based regimen as a first-line treatment for newly diagnosed nasal type extranodal natural killer cell/T-cell lymphoma.

Bu S, Yuan F, Wei X, Yin Q, Li Y, Mi R, Yang H, Li H, Ge S, Liu Y, Song Y. Bu S, et al. Exp Ther Med. 2016 Jun;11(6):2437-2445. doi: 10.3892/etm.2016.3249. Epub 2016 Apr 11. Exp Ther Med. 2016. PMID: 27313673 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

2,797 results

Search Page